Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Moss

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2014
Molecular epidemiology of Aspergillus collected from cystic fibrosis patientsRaquel Sabino, Jose A G Ferreira, Richard B Moss, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2009
Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungsMegha Makam, Daisy Diaz, Julie Laval, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2017
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutationJeffrey S Wagener, Stefanie J Millar, Nicole Mayer-Hamblett, et al.
Chest|February 11, 2004
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trialRichard B Moss, David Rodman, L Terry Spencer, et al.
Plos One|August 8, 2015
Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the BacteriumJose A G Ferreira, John C Penner, Richard B Moss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceDavid A Stevens, Richard B Moss, Viswanath P Kurup, et al.
Plos One|February 13, 2014
A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H-5T cystic fibrosis subjects taking ivacaftorJessica E Char, Marlene H Wolfe, Hyung-Ju Cho, et al.
Plos One|March 24, 2016
Earth Mover's Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell PopulationsDarya Y Orlova, Noah Zimmerman, Stephen Meehan, et al.
Pediatric Pulmonology|December 2, 2004
Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung diseaseRichard B Moss, Nicole Mayer-Hamblett, Jeffrey Wagener, et al.
The European Respiratory Journal|November 21, 2015
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosisYael Gernez, Jeffrey Waters, Bojana Mirković, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2014
Molecular epidemiology of Aspergillus collected from cystic fibrosis patientsRaquel Sabino, Jose A G Ferreira, Richard B Moss, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2009
Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungsMegha Makam, Daisy Diaz, Julie Laval, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2017
Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutationJeffrey S Wagener, Stefanie J Millar, Nicole Mayer-Hamblett, et al.
Chest|February 11, 2004
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trialRichard B Moss, David Rodman, L Terry Spencer, et al.
Plos One|August 8, 2015
Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the BacteriumJose A G Ferreira, John C Penner, Richard B Moss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus ConferenceDavid A Stevens, Richard B Moss, Viswanath P Kurup, et al.
Plos One|February 13, 2014
A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H-5T cystic fibrosis subjects taking ivacaftorJessica E Char, Marlene H Wolfe, Hyung-Ju Cho, et al.
Plos One|March 24, 2016
Earth Mover's Distance (EMD): A True Metric for Comparing Biomarker Expression Levels in Cell PopulationsDarya Y Orlova, Noah Zimmerman, Stephen Meehan, et al.
Pediatric Pulmonology|December 2, 2004
Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung diseaseRichard B Moss, Nicole Mayer-Hamblett, Jeffrey Wagener, et al.
The European Respiratory Journal|November 21, 2015
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosisYael Gernez, Jeffrey Waters, Bojana Mirković, et al.
Pageof 7